• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码 RNA BCYRN1 作为膀胱癌血清外泌体中潜在的治疗靶点和诊断标志物。

LncRNA BCYRN1 as a Potential Therapeutic Target and Diagnostic Marker in Serum Exosomes in Bladder Cancer.

机构信息

Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890-8544, Japan.

出版信息

Int J Mol Sci. 2024 May 29;25(11):5955. doi: 10.3390/ijms25115955.

DOI:10.3390/ijms25115955
PMID:38892143
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11172611/
Abstract

Bladder cancer (BC) is a common genitourinary malignancy that exhibits silent morbidity and high mortality rates because of a lack of diagnostic markers and limited effective treatments. Here, we evaluated the role of the lncRNA brain cytoplasmic RNA 1 () in BC. We performed loss-of-function assays to examine the effects of downregulation in T24 and BOY BC cells. We found that downregulation significantly inhibited the proliferation, migration, invasion, and three-dimensional spheroid formation ability and induced apoptosis in BC cells. Additionally, gene set enrichment analysis (GSEA) using RNA sequences from tumor fractions showed that downregulation decreased the expression of mRNAs associated with the cell cycle. These findings were supported by observations of G/M arrest in flow cytometry assays. Finally, we examined the expression of serum exosomal as a biomarker. Clinically, expression in serum exosomes from patients with BC ( = 31) was significantly higher than that in healthy donors ( = 19; mean difference: 4.1-fold higher, < 0.01). Moreover, in patients who had undergone complete resection of BC, serum exosomal levels were significantly decreased ( = 8). Thus, serum exosomal may be a promising diagnostic marker and therapeutic target in patients with BC.

摘要

膀胱癌(BC)是一种常见的泌尿生殖系统恶性肿瘤,由于缺乏诊断标志物和有限的有效治疗方法,其发病率和死亡率都很高。在这里,我们评估了长链非编码 RNA 脑细胞质 RNA 1()在 BC 中的作用。我们进行了功能丧失实验,以研究下调 T24 和 BOY BC 细胞中的作用。我们发现下调显著抑制了 BC 细胞的增殖、迁移、侵袭和三维球体形成能力,并诱导了细胞凋亡。此外,使用肿瘤部分的 RNA 序列进行基因集富集分析(GSEA)表明下调降低了与细胞周期相关的 mRNA 的表达。这些发现得到了流式细胞术检测到 G/M 期阻滞的观察结果的支持。最后,我们检查了血清外泌体作为生物标志物的表达。临床方面,BC 患者(=31)血清外泌体中的表达明显高于健康供体(=19;平均差异:高 4.1 倍,<0.01)。此外,在接受 BC 完全切除的患者中,血清外泌体水平显著降低(=8)。因此,血清外泌体可能是 BC 患者有前途的诊断标志物和治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8f8/11172611/56f5908551e0/ijms-25-05955-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8f8/11172611/b04fd8b814f4/ijms-25-05955-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8f8/11172611/7ce5f85d4c11/ijms-25-05955-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8f8/11172611/07528e4eafc9/ijms-25-05955-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8f8/11172611/384a2cdfd667/ijms-25-05955-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8f8/11172611/56f5908551e0/ijms-25-05955-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8f8/11172611/b04fd8b814f4/ijms-25-05955-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8f8/11172611/7ce5f85d4c11/ijms-25-05955-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8f8/11172611/07528e4eafc9/ijms-25-05955-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8f8/11172611/384a2cdfd667/ijms-25-05955-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8f8/11172611/56f5908551e0/ijms-25-05955-g005.jpg

相似文献

1
LncRNA BCYRN1 as a Potential Therapeutic Target and Diagnostic Marker in Serum Exosomes in Bladder Cancer.长链非编码 RNA BCYRN1 作为膀胱癌血清外泌体中潜在的治疗靶点和诊断标志物。
Int J Mol Sci. 2024 May 29;25(11):5955. doi: 10.3390/ijms25115955.
2
Tumor-derived exosomal BCYRN1 activates WNT5A/VEGF-C/VEGFR3 feedforward loop to drive lymphatic metastasis of bladder cancer.肿瘤来源的外泌体 BCYRN1 激活 WNT5A/VEGF-C/VEGFR3 正反馈环促进膀胱癌淋巴转移。
Clin Transl Med. 2021 Jul;11(7):e497. doi: 10.1002/ctm2.497.
3
Determination of Serum Exosomal H19 as a Noninvasive Biomarker for Bladder Cancer Diagnosis and Prognosis.血清外泌体 H19 作为膀胱癌诊断和预后的无创生物标志物的测定。
Med Sci Monit. 2018 Dec 21;24:9307-9316. doi: 10.12659/MSM.912018.
4
Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression.外泌体传递的长非编码 RNA PTENP1 抑制膀胱癌进展。
Mol Cancer. 2018 Oct 3;17(1):143. doi: 10.1186/s12943-018-0880-3.
5
BMSC-derived exosomal lncRNA PTENP1 suppresses the malignant phenotypes of bladder cancer by upregulating SCARA5 expression.骨髓间充质干细胞来源的外泌体长链非编码 RNA PTENP1 通过上调 SCARA5 的表达抑制膀胱癌的恶性表型。
Cancer Biol Ther. 2022 Dec 31;23(1):1-13. doi: 10.1080/15384047.2022.2102360.
6
Evaluation of serum exosomal LncRNA-based biomarker panel for diagnosis and recurrence prediction of bladder cancer.基于血清外泌体长链非编码 RNA 标志物panel 的膀胱癌诊断和复发预测评估。
J Cell Mol Med. 2019 Feb;23(2):1396-1405. doi: 10.1111/jcmm.14042. Epub 2018 Nov 23.
7
LncRNA BCYRN1 inhibits glioma tumorigenesis by competitively binding with miR-619-5p to regulate CUEDC2 expression and the PTEN/AKT/p21 pathway.长链非编码 RNA BCYRN1 通过与 miR-619-5p 竞争结合来抑制神经胶质瘤肿瘤发生,从而调节 CUEDC2 表达和 PTEN/AKT/p21 通路。
Oncogene. 2020 Nov;39(45):6879-6892. doi: 10.1038/s41388-020-01466-x. Epub 2020 Sep 25.
8
LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells.长链非编码 RNA MAFG-AS1 通过调控 miR-125b-5p/SphK1 轴促进膀胱癌细胞的增殖、迁移和侵袭。
Hum Cell. 2021 Mar;34(2):588-597. doi: 10.1007/s13577-020-00470-3. Epub 2021 Jan 5.
9
BCYRN1 is correlated with progression and prognosis in gastric cancer.BCYRN1 与胃癌的进展和预后相关。
Biosci Rep. 2019 Nov 29;39(11). doi: 10.1042/BSR20190505.
10
lncRNA TUC338 is a potential diagnostic biomarker for bladder cancer.长链非编码RNA TUC338是膀胱癌的一种潜在诊断生物标志物。
J Cell Biochem. 2019 Oct;120(10):18014-18019. doi: 10.1002/jcb.29104. Epub 2019 Jun 4.

引用本文的文献

1
Exosomal long non-coding RNAs in gastrointestinal cancer: chemoresistance mediators and therapeutic targets.胃肠道癌中的外泌体长链非编码RNA:化疗耐药介质与治疗靶点
J Transl Med. 2025 Aug 8;23(1):889. doi: 10.1186/s12967-025-06878-5.
2
RNA Polymerase III-Transcribed RNAs in Health and Disease: Mechanisms, Dysfunction, and Future Directions.健康与疾病中的RNA聚合酶III转录的RNA:机制、功能障碍及未来方向
Int J Mol Sci. 2025 Jun 18;26(12):5852. doi: 10.3390/ijms26125852.
3
Recent Exploration of Solid Cancer Biomarkers Hidden Within Urine or Blood Exosomes That Provide Fundamental Information for Future Cancer Diagnostics.

本文引用的文献

1
Exosomes in lung cancer metastasis, diagnosis, and immunologically relevant advances.肺癌转移、诊断和免疫相关进展中的细胞外囊泡。
Front Immunol. 2023 Dec 14;14:1326667. doi: 10.3389/fimmu.2023.1326667. eCollection 2023.
2
Engineered Exosome for Drug Delivery: Recent Development and Clinical Applications.工程化外泌体用于药物递送:最新进展与临床应用。
Int J Nanomedicine. 2023 Dec 23;18:7923-7940. doi: 10.2147/IJN.S444582. eCollection 2023.
3
Extracellular Vesicles as Delivery Systems in Disease Therapy.细胞外囊泡作为疾病治疗中的递送系统。
近期对尿液或血液外泌体中隐藏的实体癌生物标志物的探索,这些生物标志物为未来癌症诊断提供基础信息。
Diagnostics (Basel). 2025 Mar 5;15(5):628. doi: 10.3390/diagnostics15050628.
4
Epigenetic Biomarkers as a New Diagnostic Tool in Bladder Cancer-From Early Detection to Prognosis.表观遗传生物标志物作为膀胱癌的新型诊断工具——从早期检测到预后
J Clin Med. 2024 Nov 26;13(23):7159. doi: 10.3390/jcm13237159.
5
Non-coding RNAs in bladder cancer, a bridge between gut microbiota and host?膀胱癌中的非编码RNA,肠道微生物群与宿主之间的桥梁?
Front Immunol. 2024 Nov 19;15:1482765. doi: 10.3389/fimmu.2024.1482765. eCollection 2024.
6
Exploring the Spectrum of Long Non-Coding RNA CARMN in Physiological and Pathological Contexts.探讨长非编码 RNA CARMN 在生理和病理情况下的作用。
Biomolecules. 2024 Aug 6;14(8):954. doi: 10.3390/biom14080954.
Int J Mol Sci. 2023 Dec 5;24(24):17134. doi: 10.3390/ijms242417134.
4
Apoptosis and its pathways as targets for intracellular pathogens to persist in cells.细胞内病原体为在细胞内存活而将细胞凋亡及其途径作为靶点。
Parasitol Res. 2023 Dec 19;123(1):60. doi: 10.1007/s00436-023-08031-x.
5
Mesenchymal stem cell-derived exosomes as delivery vehicles for non-coding RNAs in lung diseases.间充质干细胞衍生的外泌体作为肺部疾病中非编码 RNA 的递药载体。
Biomed Pharmacother. 2024 Jan;170:116008. doi: 10.1016/j.biopha.2023.116008. Epub 2023 Dec 9.
6
MALAT1: A key regulator in lung cancer pathogenesis and therapeutic targeting.MALAT1:肺癌发病机制和治疗靶点的关键调节因子。
Pathol Res Pract. 2024 Jan;253:154991. doi: 10.1016/j.prp.2023.154991. Epub 2023 Nov 30.
7
Circulating Tumor DNA Is a Variant of Liquid Biopsy with Predictive and Prognostic Clinical Value in Breast Cancer Patients.循环肿瘤 DNA 是液体活检的一种变体,在乳腺癌患者的预测和预后中有临床价值。
Int J Mol Sci. 2023 Dec 2;24(23):17073. doi: 10.3390/ijms242317073.
8
Emerging Microfluidic Tools for Simultaneous Exosomes and Cargo Biosensing in Liquid Biopsy: New Integrated Miniaturized FFF-Assisted Approach for Colon Cancer Diagnosis.新兴的微流控工具用于液体活检中的外泌体和货物生物传感:用于结肠癌诊断的新型集成的 FFF 辅助式微型化方法。
Sensors (Basel). 2023 Nov 27;23(23):9432. doi: 10.3390/s23239432.
9
Precision Isolation of Circulating Leukemia Cells in Chronic Myelogenous Leukemia Patients Using a Novel Microfluidic Device and Its Clinical Applications.使用新型微流控装置精确分离慢性粒细胞白血病患者的循环白血病细胞及其临床应用
Cancers (Basel). 2023 Dec 3;15(23):5696. doi: 10.3390/cancers15235696.
10
The Function, Underlying Mechanism and Clinical Potential of Exosomes in Colorectal Cancer.外泌体在结直肠癌中的功能、潜在机制和临床潜力。
Front Biosci (Landmark Ed). 2023 Nov 24;28(11):302. doi: 10.31083/j.fbl2811302.